Selumetinib in Cancers With BRAF Mutations

Clinical trial NCT00888134 · COMPLETED

Trial details

NCT number: NCT00888134
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Solid Neoplasm

Start date: 2009-07-01
Primary completion: 2015-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.